TDOC Q4 2025 Earnings Call Summary | Stock Taper
Logo
Pricing Log In
TDOC

TDOC — Teladoc Health, Inc.

NYSE

Q4 2025 Earnings Call Summary

February 26, 2026

Summary of Teladoc Health Q4 2025 Earnings Call

1. Key Financial Results and Metrics

  • Q4 2025 Results:
    • Consolidated revenue: $642 million (slightly up from prior year).
    • Adjusted EBITDA: $84 million (13% margin).
    • Net loss per share: $0.14, impacted by amortization of intangible assets ($0.52) and stock-based compensation ($0.09).
  • Full Year 2025 Results:
    • Consolidated revenue: $2.53 billion (down 1.5% year-over-year).
    • Adjusted EBITDA: $281 million (11.1% margin).
    • Net loss per share: $1.14, affected by noncash goodwill impairment ($0.41) and restructuring costs ($0.11).
    • Free cash flow: $167 million; cash and cash equivalents: $781 million after retiring $550 million in convertible debt.

2. Strategic Updates and Business Highlights

  • Integrated Care Segment:
    • Revenue: $409 million in Q4 (4.7% growth year-over-year).
    • Strong performance driven by flu season and acquisitions (Catapult Health and TeleCare).
    • U.S. integrated care membership reached 101.8 million.
  • BetterHelp Segment:
    • Q4 revenue: $233 million (6.7% decline year-over-year).
    • Adjusted EBITDA improved to $18 million from $4 million in Q3, driven by reduced ad spend.
    • Focus on scaling insurance offerings, with significant growth in sessions and partnerships (e.g., AARP).
  • AI and Technology Investments: Continued emphasis on AI to enhance patient care and operational efficiency, including the launch of the Pulse data platform.

3. Forward Guidance and Outlook

  • 2026 Guidance:
    • Expected consolidated revenue: $2.47 billion to $2.59 billion (flat year-over-year).
    • Adjusted EBITDA: $266 million to $308 million (2% growth at midpoint).
    • Free cash flow: $130 million to $170 million.
    • Integrated Care revenue growth projected at 0.4% to 3.9%.
    • BetterHelp revenue expected to decline by 7% to 0.5%.
    • First quarter guidance: Revenue of $598 million to $620 million and adjusted EBITDA of $50 million to $62 million.

4. Bad News, Challenges, or Points of Concern

  • Revenue Declines: Full-year revenue down 1.5% and BetterHelp segment revenue declining 9%.
  • Membership Loss: Expected decrease in U.S. integrated care members due to government program changes and subsidy expirations.
  • Competitive Pressures: Ongoing competition in the mental health space, particularly from insurance-enabled providers, affecting cash pay business.
  • Operational Headwinds: Anticipated $5 million to $7 million headwind from tariffs and challenges in scaling insurance offerings amidst a competitive landscape.

5. Notable Q&A Insights

  • Stabilization of Business: CEO Chuck Divita acknowledged the ongoing transition from subscription to visit-based revenue models and expressed optimism about future growth driven by visit revenue.
  • Chronic Care Enrollment: Positive trends in cross-selling chronic care programs, with strong interest in bundled products.
  • Insurance Scaling: Emphasis on the growth potential of BetterHelp's insurance offerings, with expectations of significant revenue increases in 2026.
  • Market Dynamics: Mixed feedback from health plans regarding strategic partnerships, with a shift towards more meaningful discussions about cost management and service offerings.
  • Ad Spend Strategy: Acknowledgment of the correlation between ad spend and revenue, with a focus on improving efficiency and scaling insurance offerings to mitigate risks associated with reduced marketing expenditures.

Overall, while Teladoc Health demonstrated resilience in certain areas, it faces significant challenges, particularly in revenue growth and competitive pressures. The strategic focus on AI, insurance scaling, and integrated care may provide pathways for future growth.

← Q3 2025